Faculty Publications

As of August 2017, this database is no longer being updated. For the most current publications from the faculty, students, and staff of the Touro College & University System, please check our institutional repository, Touro Scholar, and email any questions or publication submissions to Scholarly Communications Librarian Donneer Missouri.

Total number of publications: 7,082

Enter a faculty name:

Administrative Offices

Graduate Schools

Health Sciences

Lander Colleges

Law Center

New York School of Career and Applied Studies (NYSCAS)

Touro University System

First Prev 1 2 3 4 Next Last
  • Alshammari, F. S., Petrofsky, J. S., Daher, N., Alzoghbieh, E. S., Dehom, S. O., & Laymon, M. S. (2014). Tactile intervention as a novel technique in improving body stability in healthy elderly and elderly with diabetes. Diabetes Technology & Therapeutics, 16(12), 822-827. doi:10.1089/dia.2014.0183

  • Alsubiheen, A., Petrofsky, J. S., Daher, N., Lohman, E., & Balbas, E. (2015). Effect of tai chi exercise combined with mental imagery theory in improving balance in a diabetic and elderly population. Medical Science Monitor, 21, 3054-3061. doi:10.12659/MSM.894243

  • Argo, T., Carnahan, R., Barnett, M. J., Holman, T., & Perry, P. J. (2011). Diabetes prevalence estimates in schizophrenia and risk factor assessment. Annals of Clinical Psychiatry, 23(2), 117-124.

  • Aruoma, O. I., Narrain, D., Indelicato, J., Bourdon, E., Murad, F. & Bahorun, T. (2014). Cognitive impairment in patients with type 2 diabetes mellitus: Perspectives and challenges. Archives of Medical and Biomedical Research, 1(2), 79-89. This material can be found here.

  • Askari, B., Wietecha, T., Hudkins, K. L., Fox, E. J., O'Brien, K. D., Kim, J., . . . Alpers, C. E. (2014). Effects of CP-900691, a novel peroxisome proliferator-activated receptor α, agonist on diabetic nephropathy in the BTBR ob/ob mouse. Laboratory Investigation, 94, 851–862. doi:10.1038/labinvest.2014.80

  • Baginsky, P. R., Jolicoeur, M., Hurlbert, L., & Revels, J. (2011). Skin autofluorescence: A tool for identification of prediabetes (preDM) and diabetes (DM). Diabetes, 60(Suppl. 1), A328-329. doi:10.2337/db11-868-1281

  • Banthia, S., Bergner, D. W., Chicos, A. B. , Ng, J., Pelchovitz, D. J., Subacius, H., . . . Kadish, A. H. (2013). Detection of cardiovascular autonomic neuropathy using exercise testing in patients with type 2 diabetes mellitus. Journal of Diabetes and Its Complications, 27(1), 64–69. doi: 10.1016/j.jdiacomp.2012.09.002

  • Casapulla, S. L., Howe, C. A., Mora, G. R., Berryman, D., Frijalva, M. J., Rojas, E. W., . . . Shubrook, J. H. (2017). Cardiometabolic risk factors, metabolic syndrome and pre-diabetes in adolescents in the Sierra region of Ecuador. Diabetology & Metabolic Syndrome, 9 [Article 24]. This material can be found here.

  • Chamberlain, J. J., Herman, W. H., Leal, S., Rhinehart, A. S., Shubrook, J. H., Skolnik, N., & Kalyani, R. R. (2017). Pharmacologic therapy for type 2 diabetes: Synopsis of the 2017 American Diabetes Association Standards of Medical Care in Diabetes. Annals of Internal Medicine, 166(8), 572-578. This material can be found here.

  • Choy, M. (2008, August). New combination pill approved for Type 2 diabetes. Drug Topics. This material can be found here.

  • Choy, M., & Lam, S. (2007). Sitagliptin: A novel drug in the treatment of type 2 diabetes. Cardiology in Review, 15(5), 264-271. doi:10.1097/CRD.0b013e318123f771

  • Choy, M., & Richman, M. (2013). Standards of medical care in diabetes: Focus on updated recommendations in hospitalized patients. Formulary, 48(6), 189-191.

  • Ciervo, C. A., Shubrook, J. H., & Grundy, P. (2015). Diabetes management within evolving health care delivery models: The osteopathic perspective [Supplemental material]. Journal of the American Osteopathic Association, 115, eS5-eS7. This material can be found here.

  • Ciervo, C. A., Shubrook, J. H., & Grundy, P. (2015). Leveraging the principles of osteopathic medicine to improve diabetes outcomes within a new era of health care reform [Supplemental material]. Journal of the American Osteopathic Association, 115, eS8-eS19. This material can be found here.

  • Clearfield, M. B. (2011). Combination lipid therapy in type 2 diabetes. Current Atherosclerosis Reports, 13(1), 1-3. doi:10.1007/s11883-010-0139-y

  • Cohen, K. R., Shinkazh, N., Frank, J., Israel, I., & Fellner, C. (2015). Pharmacological treatment of diabetic peripheral neuropathy. P & T, 40(6), 372, 375-388. This material can be found here.

  • de Groot, M., Crick, K. A., Long, M., Saha, C., & Shubrook, J. H. (2016). Lifetime duration of depressive disorders in patients with type 2 diabetes. Diabetes Care, 39(12), 2174-2181. doi:10.2337/dc16-1145

  • de Groot, M. Shubrook, J. H., Schwartz, F., Hornsby Jr., W. G., Pillay, Y., & Saha, C. (2015). Program ACTIVE II: Design and methods for a multi-center community-based depression treatment for rural and urban adults with type 2 diabetes. Journal of Diabetes Research and Therapy, 1(2). This material can be found here.

  • Dugan, J. A. (2016). Exercise recommendations for patients with type 2 diabetes. Journal of the American Academy of Physician Assistants, 29(1), 13-18. doi:10.1097/01.JAA.0000475460.77476.f6

  • Dugan, J. A. (2017). Standards of care and treatment in diabetes. Physician Assistant Clinics, 2(1), 13-23. doi:10.1016/j.cpha.2016.08.004

  • Dugan, J. A. & Parthasarathy, A. (2016). Managing diabetes in women of childbearing age. Clinician Reviews, 26(2), 51-55. This material can be found here.

  • Gehlaut, R. R., Dogbey, G. Y., Schwartz, F. L., Marling, C. R., & Shubrook, J. H. (2015). Hypoglycemia in type 2 diabetes - More common than you think: A continuous glucose monitoring study. Journal of Diabetes Science and Technology, 9(5), 999-1005. doi:10.1177/1932296815581052

  • Gerencser, A. A. (2015). Bioenergetic analysis of single pancreatic β-cells indicates an impaired metabolic signature in type 2 diabetic subjects. Endocrinology, 156(10), 3496-3503. doi:10.1210/en.2015-1552

  • Goswami, G., Shinkazh, N., & Davis, N. (2014). Optimal pharmacologic treatment strategies in obesity and type 2 diabetes. Journal of Clinical Medicine, 3(2), 595-613. doi:10.3390/jcm3020595

  • Grasso, Y. Z., Reddy, S. K., Rosenfeld, C. R., Hussein, W. I., Hoogwerf, B. J., Faiman, C., & Gupta, M. K. (2001). Autoantibodies to IA-2 and GAD65 in patients with type 2 diabetes mellitus of varied duration: Prevalence and correlation with clinical features. Endocrine Practice, 7(5), 339-345. doi:10.4158/EP.7.5.339

First Prev 1 2 3 4 Next Last